Robert Haddad
Dana-Farber Cancer Institute

Last Updated On 7/27/2021 6:12:16 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
Company: Dana-Farber Cancer Institute
Recipient: You

Leadership
Company: NCCN
Recipient: You

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Celgene
Recipient: You
Company: Merck
Recipient: You
Company: Eisai
Recipient: You
Company: Bristol-Myers Squibb
Recipient: You
Company: AstraZeneca
Recipient: You
Company: Pfizer
Recipient: You
Company: Loxo
Recipient: You
Company: Genentech
Recipient: You
Company: Immunomic Therapeutics
Recipient: You
Company: GSK
Recipient: You
Company: Gilead Sciences
Recipient: You
Company: Vaccinex
Recipient: You
Company: EMD Serono
Recipient: You
Company: BioNTech AG
Recipient: You
Company: Achilles Therapeutics
Recipient: You
Company: Bayer
Recipient: You
Company: Mirati Therapeutics
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Boehringer Ingelheim
Recipient: Your Institution
Company: Merck
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Celgene
Recipient: Your Institution
Company: AstraZeneca
Recipient: Your Institution
Company: VentiRx
Recipient: Your Institution
Company: Genentech
Recipient: Your Institution
Company: Pfizer
Recipient: Your Institution
Company: Kura
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: up to Date
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
Company: Nanobiotix
Recipient: You
Company: ISA Pharmaceuticals
Recipient: You

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered